Literature DB >> 26187360

Surgically Assisted Rapid Palatomaxillary Expansion With or Without Pterygomaxillary Disjunction: A Systematic Review and Meta-Analysis.

Adrien Hamedi Sangsari1, Pooyan Sadr-Eshkevari2, Ahmed Al-Dam3, Reinhard E Friedrich4, Earl Freymiller5, Ashkan Rashad6.   

Abstract

PURPOSE: The purpose of this review was to evaluate the outcome measurements of anterior expansion, posterior expansion, and complications after surgically assisted rapid palatal expansion (SARPE) with or without pterygomaxillary disjunction (PMD).
MATERIALS AND METHODS: A computerized database search was performed using PubMed, CINAHL, Cochrane, Scopus, and Web of Science. Then, a computerized search was conducted in Google Scholar and ProQuest to overcome publication bias.
RESULTS: From the original 125 combined results, 3 met the inclusion criteria. The Quality Assessment Tool for Quantitative Studies of the Effective Public Health Practice Project assessed 2 articles as weak and 1 as moderate. The systematic review included a total of 48 patients (11 male and 37 female). For 25 patients, SARPE was performed with PMD and for 23 patients SARPE was performed without PMD. A tooth-borne fixed hyrax-type palatal expansion screw appliance was used for all cases, activated 1 to 2 mm intraoperatively, and, after a latency period of 3 to 7 days, activated 0.5 to 0.6 mm per day for 38 patients and 0.25 mm for the other 10 until adequate expansion. Postexpansion retention was performed using ligature wired hyrax in 18 patients for 4 months. Comparisons were based on cone-beam computed tomographic projections, study models only, or a combination of study models, anteroposterior cephalometric radiographs, and occlusal radiographs. The time to measure the changes ranged from before fixed orthodontic retention to 6 months after the completion of active expansion. A meta-analysis was possible only for anterior (intercanine) and posterior (inter-molar) dental expansions.
CONCLUSION: The literature is inconclusive regarding the effect of PMD on the outcomes of SARPE. Further controlled trials are needed.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26187360     DOI: 10.1016/j.joms.2015.06.161

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  6 in total

1.  Rapid Maxillary Expansion to Correct Palatal Fracture Malunion: A Case Report.

Authors:  Sagar Dahiya; Prasad Chitra; Narahari Kalyana Srinivas Aravind; Sukhvinder Bindra
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Modified SARME (Surgically Assisted Rapid Maxillary Expansion) in Conjunction with Orthodontic Treatment-A Case Report.

Authors:  Sagar Dahiya; Prasad Chitra; Sadam Srinivas Rao; Sukhvinder Bindra
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 3.  Transverse Expansion and Stability after Segmental Le Fort I Osteotomy versus Surgically Assisted Rapid Maxillary Expansion: a Systematic Review.

Authors:  Thomas Starch-Jensen; Tue Lindberg Blæhr
Journal:  J Oral Maxillofac Res       Date:  2016-12-28

4.  Does intravenous tranexamic acid reduce blood loss during surgically assisted rapid palatal expansion?

Authors:  Emine Akbas; Zerrin Cebi; Erol Cansiz; Sabri Cemil Isler; Sırmahan Cakarer
Journal:  J Istanb Univ Fac Dent       Date:  2017-10-02

5.  Comparison of Tooth- and Bone-Borne Appliances on the Stress Distributions and Displacement Patterns in the Facial Skeleton in Surgically Assisted Rapid Maxillary Expansion-A Finite Element Analysis (FEA) Study.

Authors:  Rafał Nowak; Anna Olejnik; Hanna Gerber; Roman Frątczak; Ewa Zawiślak
Journal:  Materials (Basel)       Date:  2021-03-01       Impact factor: 3.623

6.  Evaluation of symmetry behavior of surgically assisted rapid maxillary expansion with simulation-driven targeted bone weakening.

Authors:  S Chhatwani; K Schudlich; S C Möhlhenrich; A Pugachev; A Bicsak; B Ludwig; S Hassfeld; G Danesh; L Bonitz
Journal:  Clin Oral Investig       Date:  2021-05-05       Impact factor: 3.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.